The race to produce a coronavirus vaccine accelerated on Monday when the German group BioNTech announced a $135m partnership with Fosun Pharma of China to develop a Covid-19 vaccine, which it said could begin clinical testing in late April.
研制新型冠狀病毒疫苗的競賽周一提速。德國生物技術集團BioNTech宣布與中國復星醫藥(Fosun Pharma)達成一項涉資1.35億美元的合作,以開發COVID-19疫苗。該公司表示,這種疫苗有望于4月下旬開始臨床試驗。
您已閱讀8%(352字),剩余92%(3968字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。